Key considerations in selecting a polymer prefilled syringe for low-temperature mRNA vaccines

Download the whitepaper to explore the key considerations in selecting a prefilled polymer syringe for low-temperature mRNA vaccines!

During a pandemic, the primary goal is to vaccinate as many people as possible in the shortest time. As a pandemic shifts to an endemic phase, public health experts expect periodic re-vaccination, leading to a transition from multi-dose vials to prefilled syringes for vaccination approaches. This transition raises many technical questions, especially for mRNA-based vaccines, which are highly sensitive and require low-temperature storage conditions.

Read the whitepaper to explore solutions to these technical challenges and make the transition from vials to prefilled syringes as smooth as possible!

Register for the SCHOTT ID and get access to SCHOTT Pharma exclusive content:

SCHOTT ID is your central key to valuable information and features related to our products and applications. Whether you are an interested party, customer, or partner, you can benefit from simplified access to extended content, practical tools, and digital offerings alongside our range of products.

Transparent.png